Clinique Partners with Icahn School of Medicine at Mount Sinai to Establish the Mount Sinai-Clinique Healthy Skin Dermatology Center
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Evercore ISI Positive on Estee Lauder (EL) Following Earnings
February 5, 2024 8:11 AM ESTEvercore ISI analyst Robert Ottenstein reiterated an Outperform rating and $145.00 price target on Estee Lauder (NYSE: EL).
The analyst comments "Estees 2Q EPS F24 of $0.88 represented a $0.33 upside to consensus $.55, driven by signs of stabilization in the European division, where global travel retail operates sales are still declining... More
Citi on Estee Lauder (EL): 'We expect the new restructuring plan...to drive a positive reaction today'
February 5, 2024 7:40 AM ESTCiti analyst Filippo Falorni reiterated a Neutral rating and $140.00 price target on Estee Lauder (NYSE: EL).
The analyst comments "As we highlighted in our preview, F2Q24 results were pressured by continued headwinds in Asia Pac TR & Mainland China but... More
Goldman Sachs on Estee Lauder (EL) Post Earnings: 'we expect the stock to trade higher'
February 5, 2024 7:38 AM ESTGoldman Sachs analyst Jason English reiterated a Buy rating and $141.00 price target on Estee Lauder (NYSE: EL)
The analyst comments "EL reported mixed results with a sharp sequential improvement in gross margin driving an EPS beat that was coupled with revenue that was... More

